Delivery Order SPE2DB22D1017-SPE2DB24FF6DT
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon BCISE 2 mg autoinjector medication. The contract has a ceiling value of $5,436.04 and a period of performance through July 31, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999...
- This is a $5,442.78 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a prescription medication, with a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the DLA to efficiently procure a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,662.45, is for the provision of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of the prescription medication BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, with a ceiling value of $7,866.64 and a period of performance through April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg autoinjectors, a medication used for the treatment of type 2 diabetes. The contract has a ceiling value of $4,157.22 and a period of performance through November 7, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a prescription medication, with a ceiling value of $4,755.45 and a period of performance through April 30, 2024. This delivery order is placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Bydureon BCISE, a 2 mg auto-injectable medication. The contract has a firm fixed price and a ceiling value of $9,403.22. The delivery order was awarded on July 30, 2024, with a completion date of July 31, 2024. This contract is not set aside for any specific business type. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract has a ceiling value of $21,561.94 and an ultimate completion date of May 1, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,225.53, is for the supply of Bydureon BCISE 2 mg autoinjectors. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corporation for the supply of 4,565,828,590 units of the pharmaceutical product Bydureon BCISE 2 mg AutoInject 0.85 mL. The contract has a ceiling value of $1,570.20 and is a Firm Fixed Price contract. The award date was September 16, 2024, and the ultimate completion date is September 17, 2024. AmerisourceBergen Drug Corporation is a major supplier of pharmaceutical products and medical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF6DTDelivery Order
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical supplier, for the provision of 4,564,312,600 units of the medication Bydureon BCISE 2 mg AutoInject 0.85 mL. The contract has a ceiling value of $4,270.80 and a period of performance ending on April 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific delivery order does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 4/17/24 |